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Dear Editor, 
 
Onychomycosis is a worldwide health problem. Several factors make it a 
challenging entity: difficulties confirming the diagnosis, potential side effects of 
antifungals, treatment duration and relapse. Appreciating local pathogens and 
identifying changing trends are essential for optimal management. 
 
There is no UK data concerning laboratory-diagnosed onychomycosis, therefore 
we carried out a retrospective analysis in the Southwest of England. Electronic 
records of all nail specimens received at Public Health England Mycology 
Reference Laboratory between March 2006 and December 2014 were identified. 
Data items included age, gender, microscopy/culture results and site of 
specimen. Statistical analysis was carried out using STATA®. 
 
One-sample t-tests were used to analyse if Candida sp. were split between 
genders in the same ratio as the rest of the samples. A two-sample t-test was 
used to examine whether age ranges differed between 2006 and 2014. 
Comparison of proportions were carried out using Chi squared test.  
 
A total of 38,591 nail specimens were received. There was a trend for increased 
specimen submission over the eight-year period possibly reflecting better 
awareness of onychomycosis and an ageing population.  Data from the Office of 
National Statistics demonstrates an increase in the population in the Southwest 
of England by 0.7% between 2004 – 2014, whilst the UK population of those 
aged 65+ years increased from 16% to 18%.1 Table 1 lists study population 
characteristics.  
 
Mean age for microscopy-positive nail specimens was 51.4 years (95% CI 51.2, 
51.6). The percentage of microscopy positive samples (60%) was the same for 
those aged 20-80+ years (p=0.277), and lower at 51% in those aged 0-19 years 
(p<0.001). Other studies demonstrated an increase in the rate of onychomycosis 
with age, however this was not a cross-sectional study, possibly explaining our 
differing findings. During the study period, there was a rise in microscopy-
positive samples from adults (patients aged≥16 years, p<0.001). In line with 
previous data,2 males were more commonly affected than females (microscopy 
positive results in males vs females; 54% vs 46%, p<0.001), with no change in 
this ratio over time.  
 
The presence of fungus was confirmed by direct microscopic examination of 
fungal hyphae in 22,803 (59.2%) specimens. The causative organism was 
cultured from 13,684 (35.5%) specimens. In 9,657 cases (25.0%), fungal 
elements were seen but culture was negative.  
 
Toe nail onychomycosis was much commoner (94.8%) than finger nail infection 
irrespective of patient age or gender. Thirty-seven fungal species were isolated. 
As anticipated, dermatophytes were the commonest - reported in 12,577/13,684 
(91.9%) cases, non-dermatophyte moulds (NDM) in 771/13,684 (5.6%) and 
yeasts in 336/13,684 (2.5%) specimens. Of the species isolated we could specify 
the location of the fungus for 9,845/13,684 (71.9%). Table 2 shows the 
commonest reported organism was T.rubrum; accounting for 48.7% of finger 
(n=241) and 66.9% of toenail infections (n=6,259). In fingernails the second 
most common was Candida sp. (n=202, 40.6%). In toenails it was T. interdigitale 
(n=2,480, 26.5%) followed by Fusarium (n=163, 1.7%). There was no change in 
the proportion of infections due to T. rubrum (p=0.549), T. interdigitale 
(p=0.152) or Fusarium (p=0.188) during the study period.  
 
Candida sp. (including C. albicans, C. parapsilosis and C. guilliermondii) were 
cultured in 202/495 (40.8%) fingernail specimens compared to just 18/9,344 
(0.19%) toenail samplings, Table 2. In those with confirmed Candida 
onychomycosis, 76% were female (p<0.001). An Italian study attributed similar 
findings to occupations such as housework, bar tenders and florists. Diabetes 
was also a risk factor,3 something we are unable to comment on. Clinical 
observation demonstrates that nails are generally longer in females, which 
predisposes to increased occlusion of the warm damp subungual space.  
Additionally females are more likely to undertake manicure, which provokes low 
level tissue damage and hence reduced local immunity. 
 
Onychomycosis caused by NDM depends on diagnostic criteria (Table 2 legend) 
and geography: in Europe rates range from 1-10%4 whereas in India, Jamaica, 
Nigeria, Thailand and Pakistan they range between 10-68%.5, 6 Over the last two 
decades there have been reports of increased NDM isolations worldwide 
including Italy, Greece,7 Spain8 the USA9, however our data did not support this. 
There is wide geographical variation in causative NDM onychomycosis. In North 
America, the most frequently isolated genus is Acremonium sp.10, in Europe it is 
Scopulariopsis sp.,3, 7, 8 and in Asia Aspergillus sp.11 Our study found Fusarium sp. 
to be the most common. This is particularly important to note for clinical 
practice since such a mould can be life-threatening in the setting of 
immunosuppression.12, 13 
 
We found an increase in the proportion of microscopy-positive cases that were 
culture-negative during our study period: 34.7% in 2006 vs 41.9% in 2014 
(p<0.001). This rise in culture failure could be explained in several ways: (a) 
inadequate nail sample size, highlighting the importance of obtaining generous 
specimens; (b) more distal nail sample submission, where the organism is likely 
to be older and hence non-viable, therefore it will be visible on microscopy but 
will not grow; (c) enhanced sensitivity of fungal microscopy due to calcofluor 
staining; (d) use of over the counter products, which can kill the fungus in the 
uppermost layers such that it will not grow on culture yet still be detected on 
microscopy. Of interest the Medicines & Healthcare products Regulatory Agency 
granted Galderma (UK) a licence for Loceryl®, amorolfine hydrochloride 5%, 
nail lacquer for over the counter use in April 2006, since which sales have 
increased.14 Considering the growing evidence that dermatophyte 
onychomycosis is clinically indistinguishable from that caused by other moulds, 
it is paramount to perform optimal complete mycological studies to identify the 
causative agent to guide correct treatment and maximise chances of cure.15 
 
Although this is the first study of its type from the UK, it has limitations including 
its retrospective nature and absence of clinical case information. These are 
potential areas for future study and support the notion of IT-based clinical data 
recording to access such information. 
 
Performing such studies in individual countries and regions is important for the 
continued analysis of fungal pathogens to identify changing trends that will 
influence local guidelines and hence clinical practice. 
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Variable Number Percentage of total 
Gender 
  
Female  21,342 55.3% 
Male 17,199 44.6% 
Unspecified 50 0.1% 
Mean age (years) (95% CI) 50.9 (50.7, 51.1) 
 Age range 
  0-16 years 1,434 3.7% 
17-64 years 27,144 70.3% 
65+ years 9,911 25.7% 
Unknown 102 0.3% 
Site 
  Finger 2,780 7.2% 
Toe 25,262 65.5% 
Unspecified 10,549 27.3% 
Microscopy 
  No Fungus 15,727 40.8% 
Fungal elements 22,803 59.0% 
Yeast  61 0.2% 
Culture  
  No fungus isolated 24,907 64.5% 
Culture positive 13,684 35.5% 
Culture results 
  
Dermatophytes 12,577 91.9% 
Non-dermatophyte mould 771 5.6% 
Yeasts 336 2.5% 
Season specimen received 
  Winter 19,432 50.4% 
Summer 19,159 49.7% 
 
Table 1.  Characteristics of the study population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Frequency (% of all cultured organisms) 
Organism   Finger Toe Total 
Dermatophyte 269 (54%) 8788 (94%) 9057 (92%) 
Trichophyton rubrum 241 (48.69%) 6259 (66.98%) 6500 (66.06%) 
Trichophyton interdigitale 21 (4.24%) 2480 (26.54%) 2501 (25.42%) 
Epidermophyton floccosum 0 (0.00%) 20 (0.21%) 20 (0.02%) 
Trichophyton sp.1 0 (0.00%) 16 (0.17%) 16 (0.16%) 
Trichophyton mentagrophytes 1 (0.20%) 4 (0.04%) 5 (0.05%) 
Trichophyton violaceum 2 (0.40%) 2 (0.02%) 4 (0.04%) 
Trichophyton erinacei 1 (0.20%) 2 (0.02%) 3 (0.03%) 
Trichophyton soudanense 1 (0.20%) 2 (0.02%) 3 (0.03%) 
Microsporum audouinii 0 (0.00%) 1 (0.01%) 1 (0.01%) 
Microsporum canis 1 (0.20%) 0 (0.00%) 1 (0.01%) 
Trichophyton terrestre 0 (0.00%) 1 (0.01%) 1 (0.01%) 
Trichophyton tonsurans 1 (0.20%) 0 (0.00%) 1 (0.01%) 
Trichophyton verrucosum 0 (0.00%) 1 (0.01%) 1 (0.01%) 
Non-Dermatophyte 229 (46%) 559 (6%) 788 (8%) 
Candida sp. ♯ 202 (40.56%) 18 (0.19%) 220 (2.36%) 
Fusarium sp. 18 (3.61%) 163 (1.74%) 181 (1.94%) 
Scopulariopsis brevicaulis 0 (0.00%) 93 (0.99%) 93 (0.99%) 
Acremonium sp. 1 (0.20%) 77 (0.82%) 78 (0.83%) 
Aspergillus versicolor 0 (0.00%) 80 (0.86%) 80 (0.86%) 
Aspergillus terreus complex 0 (0.00%) 43 (0.46%) 43 (0.46%) 
Neoscytalidium dimidiatum 4 (0.80%) 31 (0.33%) 35 (0.37%) 
Aspergillus sp. 0 (0.00%) 24 (0.26%) 24 (0.26%) 
Purpureocillium lilacinum 0 (0.00%) 11 (0.12%) 11 (0.12%) 
Penicillium sp. 1 (0.20%) 5 (0.05%) 6 (0.06%) 
Neoscytalidium hyalinum 0 (0.00%) 5 (0.05%) 5 (0.05%) 
Scedosporium apiospermum 0 (0.00%) 3 (0.03%) 3 (0.03%) 
Onychocola canadensis 0 (0.00%) 2 (0.02%) 2 (0.02%) 
Phoma sp. 0 (0.00%) 1 (0.01%) 1 (0.01%) 
Exophilala sp. 1 (0.20%) 0 (0.00%) 1 (0.01%) 
Exserohilum sp. 0 (0.00%) 1 (0.01%) 1 (0.01%) 
Geotrichum candidum 1 (0.20%) 0 (0.00%) 1 (0.01%) 
Lichtheimia corymbifera 1 (0.20%) 0 (0.00%) 1 (0.01%) 
Ochroconis sp. 0 (0.00%) 1 (0.01%) 1 (0.01%) 
Trichosporon mucoides 0 (0.00%) 1 (0.01%) 1 (0.01%) 
Table 2. Species according to site of nail infection.  These results exclude the 
specimens from unspecified sites. 1this group are likely to be mutant variants of 
the common species, which were not displaying sufficient morphological 
characteristics for full phenotypic identification.♯=yeasts. 
Processing of nail samples was conducted in accordance with the standard 
operating procedures for dermatological samples produced by Public Health 
England. Nail fragments were digested in 20% Potassium hydroxide and stained 
with calcofluor white. They were viewed under a fluorescence microscope and 
cultured on Sabouraud media (glucose-peptone agar containing 0.05mg/ml of 
chloramphenicol) with and without acitidione. Fungal growth was examined 
after 1 and 2 weeks incubation at 30oC. Samples were reported as negative if 
there was no growth after observation for 2 weeks.  Structures visible on 
microscopy were recorded e.g. arthroconidia (indicative of a dermatophyte 
infection) or fronding and swelling (indicative of non-dermatophyte mould), or 
yeast cells only, or yeast cells plus hyphae (indicative of infection with a 
filamentous yeast). Isolates were identified by means of colonial morphology and 
direct microscopy to observe the method of spore formation, or in the case of 
yeast isolates by morphology and the use of commercial carbohydrate 
assimilation tests or Matrix-Assisted Laser Desorption/Ionisation – Time of 
Flight (MALDI-ToF) Mass Spectrometry techniques. Local reporting rules were 
followed which include; always reporting a dermatophyte isolation despite the 
microscopy result as dermatophytes are not encountered as commensal 
organisms. In contrast, NDMs would only be reported if grown from at least four 
specimen portions, in pure culture, from a microscopy positive nail. Non-
dermatophyte moulds are frequently cultured from dystrophic or indeed healthy 
nails, which are contaminated with fungal spores from the environment. 
However, observation of hyphae within the tissue indicates active growth, 
sometimes these may be hyphae of an underlying dermatophyte which has 
damaged the nail allowing secondary colonisation with a NDM. If a 
dermatophyte and a NDM were isolated the dermatophyte would be considered 
to be the primary pathogen. Yeasts would only be reported if accompanied by 
positive microscopy.  
 
 
 
 
 
 
  
 
 
